338 related articles for article (PubMed ID: 32752303)
21. Early cannabinoid exposure influences neuroendocrine and reproductive functions in mice: II. Postnatal effects.
Dalterio S; Steger R; Mayfield D; Bartke A
Pharmacol Biochem Behav; 1984 Jan; 20(1):115-23. PubMed ID: 6320228
[TBL] [Abstract][Full Text] [Related]
22. The effects of Delta-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation and in vitro motility disturbances in rat colitis.
Jamontt JM; Molleman A; Pertwee RG; Parsons ME
Br J Pharmacol; 2010 Jun; 160(3):712-23. PubMed ID: 20590574
[TBL] [Abstract][Full Text] [Related]
23. Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats.
Javadi-Paydar M; Nguyen JD; Kerr TM; Grant Y; Vandewater SA; Cole M; Taffe MA
Psychopharmacology (Berl); 2018 Sep; 235(9):2541-2557. PubMed ID: 29907926
[TBL] [Abstract][Full Text] [Related]
24. Receptor-mediated effects of Δ
Preteroti MW; Traboulsi H; Greiss P; Lapohos O; Fonseca GJ; Eidelman DH; Baglole CJ
Immunol Cell Biol; 2023 Feb; 101(2):156-170. PubMed ID: 36510483
[TBL] [Abstract][Full Text] [Related]
25. Effects of Cannabidiol, ∆9-Tetrahydrocannabinol, and WIN 55-212-22 on the Viability of Canine and Human Non-Hodgkin Lymphoma Cell Lines.
Omer S; Pathak S; Mansour M; Nadar R; Bowen D; Dhanasekaran M; Pondugula SR; Boothe D
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672512
[TBL] [Abstract][Full Text] [Related]
26. ¹H NMR and HPLC/DAD for Cannabis sativa L. chemotype distinction, extract profiling and specification.
Peschel W; Politi M
Talanta; 2015 Aug; 140():150-165. PubMed ID: 26048837
[TBL] [Abstract][Full Text] [Related]
27. Cannabinoid use is enhanced by stress and changes conditioned stress responses.
Hodebourg R; Meyerink ME; Crow AD; Reichel CM; Kalivas PW; Garcia-Keller C
Neuropsychopharmacology; 2022 Apr; 47(5):1037-1045. PubMed ID: 35145212
[TBL] [Abstract][Full Text] [Related]
28. The combination of cannabidiol and Δ9-tetrahydrocannabinol enhances the anticancer effects of radiation in an orthotopic murine glioma model.
Scott KA; Dalgleish AG; Liu WM
Mol Cancer Ther; 2014 Dec; 13(12):2955-67. PubMed ID: 25398831
[TBL] [Abstract][Full Text] [Related]
29. Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER
Amaral C; Trouille FM; Almeida CF; Correia-da-Silva G; Teixeira N
J Steroid Biochem Mol Biol; 2021 Jun; 210():105876. PubMed ID: 33722705
[TBL] [Abstract][Full Text] [Related]
30. Neuroprotective Effects of Cannabidiol but Not Δ
Landucci E; Mazzantini C; Lana D; Davolio PL; Giovannini MG; Pellegrini-Giampietro DE
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575932
[TBL] [Abstract][Full Text] [Related]
31. Neuromolecular Mechanisms of Cannabis Action.
Adel Y; Alexander SPH
Adv Exp Med Biol; 2021; 1264():15-28. PubMed ID: 33332001
[TBL] [Abstract][Full Text] [Related]
32. Δ
Silveira MM; Adams WK; Morena M; Hill MN; Winstanley CA
J Psychiatry Neurosci; 2017 Mar; 42(2):131-138. PubMed ID: 28245177
[TBL] [Abstract][Full Text] [Related]
33. In Vitro Effect of Δ9-Tetrahydrocannabinol and Cannabidiol on Cancer-Associated Fibroblasts Isolated from Lung Cancer.
Milián L; Monleón-Guinot I; Sancho-Tello M; Galbis JM; Cremades A; Almenar-Ordaz M; Peñaroja-Martinez J; Farras R; Martín de Llano JJ; Carda C; Mata M
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743206
[TBL] [Abstract][Full Text] [Related]
34. Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells.
Scott KA; Dennis JL; Dalgleish AG; Liu WM
Anticancer Res; 2015 Nov; 35(11):5827-37. PubMed ID: 26504004
[TBL] [Abstract][Full Text] [Related]
35. The effects of delta 9-tetrahydrocannabinol alone and in combination with cannabidiol on fixed-interval performance in rhesus monkeys.
Brady KT; Balster RL
Psychopharmacology (Berl); 1980; 72(1):21-6. PubMed ID: 6258188
[TBL] [Abstract][Full Text] [Related]
36. Effects of delta-9-tetrahydrocannabinol, cannabinol and cannabidiol, alone and in combinations, on luteinizing hormone and prolactin release and on hypothalamic neurotransmitters in the male rat.
Murphy LL; Steger RW; Smith MS; Bartke A
Neuroendocrinology; 1990 Oct; 52(4):316-21. PubMed ID: 1979838
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite.
El-Remessy AB; Khalil IE; Matragoon S; Abou-Mohamed G; Tsai NJ; Roon P; Caldwell RB; Caldwell RW; Green K; Liou GI
Am J Pathol; 2003 Nov; 163(5):1997-2008. PubMed ID: 14578199
[TBL] [Abstract][Full Text] [Related]
38. Delta9-THC as a discriminative cue in pigeons: effects of delta8-THC, CBD, and CBN.
Järbe TU; Henriksson BG; Ohlin GC
Arch Int Pharmacodyn Ther; 1977 Jul; 228(1):68-72. PubMed ID: 921403
[TBL] [Abstract][Full Text] [Related]
39. Effect of cannabinoids on the turnover rate of acetylcholine in rat hippocampus, striatum and cortex.
Revuelta AV; Moroni F; Cheney DL; Costa E
Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):107-10. PubMed ID: 703853
[TBL] [Abstract][Full Text] [Related]
40. Model-based analysis on systemic availability of co-administered cannabinoids after controlled vaporised administration.
Liu Z; Galettis P; Broyd SJ; van Hell H; Greenwood LM; de Krey P; Steigler A; Zhu X; Schneider J; Solowij N; Martin JH
Intern Med J; 2020 Jul; 50(7):846-853. PubMed ID: 31264294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
